News Releases
Boyd Street Ventures Invests in Biotech Innovator Cadenza Bio
Biotech firm aims to halt the progression of multiple sclerosis.
Wheeler Bio uses an innovative machine learning-built platform to revolutionize the speed of drug development.
Biotech firm aims to halt the progression of multiple sclerosis.
Firm is developing novel intranasal and oral vaccines based on SC-AdVax platform licensed from the Mayo Clinic.
Two Black-led organizations partner to provide guidance and funding to BIPOC founders of promising businesses.